|
0
|
|
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
(nejm.org)
|
Cuker A
…
Zaja F
New England Journal of Medicine
2026-04-16
|
#antibody
#clinical trial
#immunotherapy
#thrombocytopenia
|
|
0
|
|
B lymphocyte protein factories produced by hematopoietic stem cell gene editing.
(science.org)
|
Hartweger H
…
Nussenzweig MC
Science
2026-04-16
|
#antibody
#immunotherapy
#genome editing
#cell therapy
|
|
0
|
|
Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature.
(linkinghub.elsevier.com)
|
Subudhi S
…
Jain RK
Cell
2026-04-16
|
#cancer
#immunotherapy
#microenvironment
#hypoxia
#angiogenesis
|
|
0
|
|
SnapShot: The hallmarks of cancer treatment.
(linkinghub.elsevier.com)
|
Vitiello PP
…
Bardelli A
Cell
2026-04-16
|
#amr
#cancer
#immunotherapy
#chemotherapy
#targeted therapy
|
|
0
|
|
Improving immunotherapy in solid tumors using FMT.
(linkinghub.elsevier.com)
|
Davar D
…
Trinchieri G
Cell
2026-04-16
|
#microbiome
#metabolism
#immunity
#cancer
#immunotherapy
|
|
0
|
|
Sorting out extracellular proteins: SORTACs harness sortilin for targeted protein degradation.
(linkinghub.elsevier.com)
|
Zhou C
…
Zhang X
Cell Chemical Biology
2026-04-16
|
#endocytosis
#immunotherapy
#proteolysis
#degradation
|
|
0
|
|
Cell death in cancer.
(linkinghub.elsevier.com)
|
Conrad M
…
Wahida A
Cell
2026-04-16
|
#cancer
#immunotherapy
#ferroptosis
#apoptosis
#necroptosis
|
|
0
|
|
Hallmarks of liver cancer: Therapeutic implications.
(linkinghub.elsevier.com)
|
Llovet JM
…
Villanueva A
Cell
2026-04-16
|
#metabolism
#virulence
#cancer
#immunotherapy
|
|
0
|
|
Mapping intratumor heterogeneity across layers for advancing immunotherapy.
(linkinghub.elsevier.com)
|
Marine JC
…
Samuels Y
Cell
2026-04-16
|
#cancer
#immunotherapy
#antigen
#heterogeneity
#immunopeptidomics
|